Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates-Reference-Cited by-同舟云学术

Impact of Neoadjuvant Chemotherapy in Stage II–III Triple Negative Breast Cancer on Eligibility for Breast-conserving Surgery and Breast Conservation Rates

Published:2015-09 Issue:3 Volume:262 Page:434-439
ISSN:0003-4932
Container-title:Annals of Surgery
language:en
Short-container-title:

Author:

Golshan Mehra,Cirrincione Constance T.,Sikov William M.,Berry Donald A.,Jasinski Sara,Weisberg Tracey F.,Somlo George,Hudis Clifford,Winer Eric,Ollila David W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference18 articles.

1. Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project protocols B-18 and B-27.;Rastogi;J Clin Oncol,2008

2. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.;Mauri;J Natl Cancer Inst,2005

3. Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.;Van der Hage;J Clin Oncol,2001

4. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.;Liedtke;J Clin Oncol,2008

5. Impact of the addition of carboplatin andor bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).;Sikov;J Clin Oncol,2015

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer;Journal of Cancer Research and Clinical Oncology;2024-08-01

2. Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022;The Breast;2024-08

3. Development and validation of a nomogram to predict pathological complete response following neoadjuvant chemotherapy in luminal breast cancer based on clinicopathological features;2024-07-26

4. Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study;Annals of Surgical Oncology;2024-07-05

5. Systemic Therapy Advances for HER2-Positive and Triple Negative Breast Cancer: What the Surgeon Needs to Know;Clinical Breast Cancer;2024-06